Vorapaxar Sulfate | Interleukin Related interleukin-related.com

Product Name :
Vorapaxar Sulfate

Search keywords :
PAR

drugId :
null

Target Vo:
Protease-activated receptor-1

Target Vo Short Name :
PAR-1

Moa_Name:
Protease-activated receptor-1 antagonists

First Approval Country :
United States

First Approval Date Filter:
2014

Origin Company_Name :
Merck Sharp & Dohme Corp

Active Company_Name :
Key Therapeutics LLC

Active Indication_Name:
Coronary Thrombosis

In Active Indication_Name:
Arteriovenous Fistula

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
BRCA1 Antibody (YA819)
CD81 Antibody
Cyclin D2 Antibody (YA789): Cyclin D2 Antibody (YA789) is a non-conjugated and Mouse origined monoclonal antibody about 33 kDa, targeting to Cyclin D2 (6E11). It can be used for WB assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts